1795153-63-7
Chemical Structure
Rupatadine-d4 fumarate
Synonym(s): UR-12592 D4 fumarate
- CAS No.: 1795153-63-7
- Formula:C30H26D4ClN3O4
- Molecular Weight:536.05
IUPAC Name: 8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-ylidene-2,2,6,6-d4)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine fumarate
InChIKey: JYBLCDXVHQWMSU-IKABZUPCSA-N
SMILES: CC1=CN=CC(CN2C([2H])([2H])C/C(CC2([2H])[2H])=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C5\3)=C1.OC(/C=C/C(O)=O)=O
Biological Activity: Rupatadine-d4 fumarate is a deuterium labeled Rupatadine fumarate. Rupatadine Fumarate (UR-12592 Fumarate) is a potent dual PAF/H1 antagonist with Ki values of 0.55/0.1 μM (rabbit platelet membranes/guinea pig cerebellum membranes)[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Rupatadine-d4 fumarate | Rupatadine-d4 fumarate is a deuterium labeled Rupatadine fumarate. Rupatadine Fumarate (UR-12592 Fumarate) is a potent dual PAF/H1 antagonist with Ki values of 0.55/0.1 μM (rabbit platelet membranes/guinea pig cerebellum membranes). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rupatadine Fumarate (Standard) | 97.25% | Rupatadine (Fumarate) (Standard) is the analytical standard of Rupatadine (Fumarate). This product is intended for research and analytical applications. Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Rupatadine Fumarate | 99.99% | Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Merlos M, et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther. 1997 Jan;280(1):114-21. [Content Brief]
- [2]. Queralt M, et al. In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1. Inflamm Res. 2000 Jul;49(7):355-60. [Content Brief]
- [3]. Lv XX, et al. Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents. PLoS One. 2013 Jul 15;8(7):e68631. [Content Brief]
